MIRA Pharmaceuticals (MIRA) Competitors $1.30 -0.05 (-3.70%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$1.31 +0.01 (+0.46%) As of 09/25/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA vs. COYA, LITS, VTGN, IRD, WHWK, IZTC, IFRX, PLRX, VXRT, and CNTBShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Coya Therapeutics (COYA), Lite Strategy (LITS), VistaGen Therapeutics (VTGN), Opus Genetics (IRD), Whitehawk Therapeutics (WHWK), Invizyne Technologies (IZTC), InflaRx (IFRX), Pliant Therapeutics (PLRX), Vaxart (VXRT), and Connect Biopharma (CNTB). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Its Competitors Coya Therapeutics Lite Strategy VistaGen Therapeutics Opus Genetics Whitehawk Therapeutics Invizyne Technologies InflaRx Pliant Therapeutics Vaxart Connect Biopharma Coya Therapeutics (NASDAQ:COYA) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Do institutionals and insiders believe in COYA or MIRA? 39.8% of Coya Therapeutics shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 12.0% of Coya Therapeutics shares are held by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate COYA or MIRA? Coya Therapeutics currently has a consensus price target of $16.50, indicating a potential upside of 210.73%. MIRA Pharmaceuticals has a consensus price target of $17.00, indicating a potential upside of 1,207.69%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Coya Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is COYA or MIRA more profitable? Coya Therapeutics' return on equity of -61.05% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Coya TherapeuticsN/A -61.05% -53.61% MIRA Pharmaceuticals N/A -406.70%-328.44% Which has stronger valuation and earnings, COYA or MIRA? MIRA Pharmaceuticals has lower revenue, but higher earnings than Coya Therapeutics. Coya Therapeutics is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoya Therapeutics$3.55M25.02-$14.88M-$1.24-4.28MIRA PharmaceuticalsN/AN/A-$7.85M-$0.49-2.65 Does the media refer more to COYA or MIRA? In the previous week, Coya Therapeutics had 2 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 5 mentions for Coya Therapeutics and 3 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 0.46 beat Coya Therapeutics' score of 0.44 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coya Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MIRA Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility and risk, COYA or MIRA? Coya Therapeutics has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. SummaryMIRA Pharmaceuticals beats Coya Therapeutics on 8 of the 15 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.74M$3.13B$5.74B$10.39BDividend YieldN/A2.39%5.75%4.64%P/E Ratio-2.6520.6375.8726.11Price / SalesN/A442.69552.25124.93Price / CashN/A44.6737.5461.24Price / Book10.009.6212.386.30Net Income-$7.85M-$52.73M$3.29B$271.03M7 Day Performance4.00%1.81%0.27%-0.14%1 Month Performance-6.47%5.50%2.79%5.82%1 Year Performance21.50%18.12%60.41%27.63% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.9021 of 5 stars$1.30-3.7%$17.00+1,207.7%+18.2%$25.74MN/A-2.652Positive NewsCOYACoya Therapeutics2.6706 of 5 stars$5.47-0.5%$16.50+201.6%-12.2%$91.99M$3.55M-4.416News CoverageLITSLite StrategyN/A$2.58-7.9%N/AN/A$91.95M$65.30M0.00100News CoverageVTGNVistaGen Therapeutics1.1513 of 5 stars$3.33+11.7%N/A+10.1%$91.43M$490K-1.8740Positive NewsHigh Trading VolumeIRDOpus Genetics2.3227 of 5 stars$1.71+12.5%$7.33+328.8%N/A$91.06M$10.99M-0.8914Positive NewsHigh Trading VolumeWHWKWhitehawk Therapeutics1.0736 of 5 stars$1.90-1.0%N/AN/A$90.49M$25.98M-31.6721IZTCInvizyne TechnologiesN/A$14.47+5.2%N/AN/A$90.47MN/A0.0029IFRXInflaRx3.1731 of 5 stars$1.35+0.7%$6.20+359.3%-15.1%$89.96M$180K-1.6960Gap UpPLRXPliant Therapeutics4.0079 of 5 stars$1.50+4.9%$8.19+445.8%-87.3%$87.79M$1.58M-0.4490Positive NewsVXRTVaxart1.9348 of 5 stars$0.38-1.0%$2.00+422.1%-54.3%$87.71M$47.40M-1.42120Gap DownCNTBConnect Biopharma3.6492 of 5 stars$1.58+0.6%$7.00+343.0%+32.0%$87.48M$26.03M0.00110Gap Up Related Companies and Tools Related Companies Coya Therapeutics Competitors Lite Strategy Competitors VistaGen Therapeutics Competitors Opus Genetics Competitors Whitehawk Therapeutics Competitors Invizyne Technologies Competitors InflaRx Competitors Pliant Therapeutics Competitors Vaxart Competitors Connect Biopharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRA) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredMagnificent 7 being replaced by the “Secret 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts